Global Endocannabinoid System Targeted Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Endocannabinoid System Targeted Therapeutics Market Size 2017-2028

2.1.2 Endocannabinoid System Targeted Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Endocannabinoid System Targeted Therapeutics Segment by Type

2.2.1 Oral

2.2.2 Inhalation

2.2.3 Others

2.3 Endocannabinoid System Targeted Therapeutics Market Size by Type

2.3.1 Endocannabinoid System Targeted Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Endocannabinoid System Targeted Therapeutics Segment by Application

2.4.1 Autoimmune Disorders

2.4.2 Genetic Disorders

2.4.3 Neurological Disorders

2.4.4 Pain Disorders

2.5 Endocannabinoid System Targeted Therapeutics Market Size by Application

2.5.1 Endocannabinoid System Targeted Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2017-2022)

3 Endocannabinoid System Targeted Therapeutics Market Size by Player

3.1 Endocannabinoid System Targeted Therapeutics Market Size Market Share by Players

3.1.1 Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Endocannabinoid System Targeted Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Endocannabinoid System Targeted Therapeutics by Regions

4.1 Endocannabinoid System Targeted Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Endocannabinoid System Targeted Therapeutics Market Size Growth (2017-2022)

4.3 APAC Endocannabinoid System Targeted Therapeutics Market Size Growth (2017-2022)

4.4 Europe Endocannabinoid System Targeted Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Endocannabinoid System Targeted Therapeutics Market Size by Country (2017-2022)

5.2 Americas Endocannabinoid System Targeted Therapeutics Market Size by Type (2017-2022)

5.3 Americas Endocannabinoid System Targeted Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Endocannabinoid System Targeted Therapeutics Market Size by Region (2017-2022)

6.2 APAC Endocannabinoid System Targeted Therapeutics Market Size by Type (2017-2022)

6.3 APAC Endocannabinoid System Targeted Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Endocannabinoid System Targeted Therapeutics by Country (2017-2022)

7.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2017-2022)

7.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Endocannabinoid System Targeted Therapeutics Market Forecast

10.1 Global Endocannabinoid System Targeted Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Endocannabinoid System Targeted Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Endocannabinoid System Targeted Therapeutics Forecast

10.1.3 APAC Endocannabinoid System Targeted Therapeutics Forecast

10.1.4 Europe Endocannabinoid System Targeted Therapeutics Forecast

10.1.5 Middle East & Africa Endocannabinoid System Targeted Therapeutics Forecast

10.2 Americas Endocannabinoid System Targeted Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Endocannabinoid System Targeted Therapeutics Market Forecast

10.2.2 Canada Endocannabinoid System Targeted Therapeutics Market Forecast

10.2.3 Mexico Endocannabinoid System Targeted Therapeutics Market Forecast

10.2.4 Brazil Endocannabinoid System Targeted Therapeutics Market Forecast

10.3 APAC Endocannabinoid System Targeted Therapeutics Forecast by Region (2023-2028)

10.3.1 China Endocannabinoid System Targeted Therapeutics Market Forecast

10.3.2 Japan Endocannabinoid System Targeted Therapeutics Market Forecast

10.3.3 Korea Endocannabinoid System Targeted Therapeutics Market Forecast

10.3.4 Southeast Asia Endocannabinoid System Targeted Therapeutics Market Forecast

10.3.5 India Endocannabinoid System Targeted Therapeutics Market Forecast

10.3.6 Australia Endocannabinoid System Targeted Therapeutics Market Forecast

10.4 Europe Endocannabinoid System Targeted Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Endocannabinoid System Targeted Therapeutics Market Forecast

10.4.2 France Endocannabinoid System Targeted Therapeutics Market Forecast

10.4.3 UK Endocannabinoid System Targeted Therapeutics Market Forecast

10.4.4 Italy Endocannabinoid System Targeted Therapeutics Market Forecast

10.4.5 Russia Endocannabinoid System Targeted Therapeutics Market Forecast

10.5 Middle East & Africa Endocannabinoid System Targeted Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Endocannabinoid System Targeted Therapeutics Market Forecast

10.5.2 South Africa Endocannabinoid System Targeted Therapeutics Market Forecast

10.5.3 Israel Endocannabinoid System Targeted Therapeutics Market Forecast

10.5.4 Turkey Endocannabinoid System Targeted Therapeutics Market Forecast

10.5.5 GCC Countries Endocannabinoid System Targeted Therapeutics Market Forecast

10.6 Global Endocannabinoid System Targeted Therapeutics Forecast by Type (2023-2028)

10.7 Global Endocannabinoid System Targeted Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GW Pharmaceuticals

11.1.1 GW Pharmaceuticals Company Information

11.1.2 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered

11.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GW Pharmaceuticals Main Business Overview

11.1.5 GW Pharmaceuticals Latest Developments

11.2 MAKScientific

11.2.1 MAKScientific Company Information

11.2.2 MAKScientific Endocannabinoid System Targeted Therapeutics Product Offered

11.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 MAKScientific Main Business Overview

11.2.5 MAKScientific Latest Developments

11.3 Corbus Pharmaceuticals

11.3.1 Corbus Pharmaceuticals Company Information

11.3.2 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered

11.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Corbus Pharmaceuticals Main Business Overview

11.3.5 Corbus Pharmaceuticals Latest Developments

11.4 Tilray

11.4.1 Tilray Company Information

11.4.2 Tilray Endocannabinoid System Targeted Therapeutics Product Offered

11.4.3 Tilray Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Tilray Main Business Overview

11.4.5 Tilray Latest Developments

11.5 Pure Green

11.5.1 Pure Green Company Information

11.5.2 Pure Green Endocannabinoid System Targeted Therapeutics Product Offered

11.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Pure Green Main Business Overview

11.5.5 Pure Green Latest Developments

11.6 Avicanna

11.6.1 Avicanna Company Information

11.6.2 Avicanna Endocannabinoid System Targeted Therapeutics Product Offered

11.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Avicanna Main Business Overview

11.6.5 Avicanna Latest Developments

11.7 GB Sciences

11.7.1 GB Sciences Company Information

11.7.2 GB Sciences Endocannabinoid System Targeted Therapeutics Product Offered

11.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 GB Sciences Main Business Overview

11.7.5 GB Sciences Latest Developments

11.8 Botanix Pharmaceuticals

11.8.1 Botanix Pharmaceuticals Company Information

11.8.2 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered

11.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Botanix Pharmaceuticals Main Business Overview

11.8.5 Botanix Pharmaceuticals Latest Developments

11.9 Therapix Biosciences

11.9.1 Therapix Biosciences Company Information

11.9.2 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Offered

11.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Therapix Biosciences Main Business Overview

11.9.5 Therapix Biosciences Latest Developments

11.10 Zelira Therapeutics

11.10.1 Zelira Therapeutics Company Information

11.10.2 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Offered

11.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Zelira Therapeutics Main Business Overview

11.10.5 Zelira Therapeutics Latest Developments

12 Research Findings and Conclusion

Table 1. Endocannabinoid System Targeted Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Oral

Table 3. Major Players of Inhalation

Table 4. Major Players of Others

Table 5. Endocannabinoid System Targeted Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2017-2022)

Table 8. Endocannabinoid System Targeted Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2017-2022)

Table 11. Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Player (2020-2022)

Table 13. Endocannabinoid System Targeted Therapeutics Key Players Head office and Products Offered

Table 14. Endocannabinoid System Targeted Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Endocannabinoid System Targeted Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Regions (2017-2022)

Table 19. Americas Endocannabinoid System Targeted Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country (2017-2022)

Table 21. Americas Endocannabinoid System Targeted Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2017-2022)

Table 23. Americas Endocannabinoid System Targeted Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2017-2022)

Table 25. APAC Endocannabinoid System Targeted Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2017-2022)

Table 27. APAC Endocannabinoid System Targeted Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2017-2022)

Table 29. APAC Endocannabinoid System Targeted Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2017-2022)

Table 31. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country (2017-2022)

Table 33. Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2017-2022)

Table 35. Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Endocannabinoid System Targeted Therapeutics

Table 44. Key Market Challenges & Risks of Endocannabinoid System Targeted Therapeutics

Table 45. Key Industry Trends of Endocannabinoid System Targeted Therapeutics

Table 46. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 52. GW Pharmaceuticals Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors

Table 53. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered

Table 54. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. GW Pharmaceuticals Main Business

Table 56. GW Pharmaceuticals Latest Developments

Table 57. MAKScientific Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors

Table 58. MAKScientific Endocannabinoid System Targeted Therapeutics Product Offered

Table 59. MAKScientific Main Business

Table 60. MAKScientific Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. MAKScientific Latest Developments

Table 62. Corbus Pharmaceuticals Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors

Table 63. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered

Table 64. Corbus Pharmaceuticals Main Business

Table 65. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Corbus Pharmaceuticals Latest Developments

Table 67. Tilray Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors

Table 68. Tilray Endocannabinoid System Targeted Therapeutics Product Offered

Table 69. Tilray Main Business

Table 70. Tilray Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Tilray Latest Developments

Table 72. Pure Green Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors

Table 73. Pure Green Endocannabinoid System Targeted Therapeutics Product Offered

Table 74. Pure Green Main Business

Table 75. Pure Green Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Pure Green Latest Developments

Table 77. Avicanna Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors

Table 78. Avicanna Endocannabinoid System Targeted Therapeutics Product Offered

Table 79. Avicanna Main Business

Table 80. Avicanna Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Avicanna Latest Developments

Table 82. GB Sciences Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors

Table 83. GB Sciences Endocannabinoid System Targeted Therapeutics Product Offered

Table 84. GB Sciences Main Business

Table 85. GB Sciences Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. GB Sciences Latest Developments

Table 87. Botanix Pharmaceuticals Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors

Table 88. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offered

Table 89. Botanix Pharmaceuticals Main Business

Table 90. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Botanix Pharmaceuticals Latest Developments

Table 92. Therapix Biosciences Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors

Table 93. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Offered

Table 94. Therapix Biosciences Main Business

Table 95. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Therapix Biosciences Latest Developments

Table 97. Zelira Therapeutics Details, Company Type, Endocannabinoid System Targeted Therapeutics Area Served and Its Competitors

Table 98. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Offered

Table 99. Zelira Therapeutics Main Business

Table 100. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Zelira Therapeutics Latest Developments

List of Figures

Figure 1. Endocannabinoid System Targeted Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type in 2021

Figure 7. Endocannabinoid System Targeted Therapeutics in Autoimmune Disorders

Figure 8. Global Endocannabinoid System Targeted Therapeutics Market: Autoimmune Disorders (2017-2022) & ($ Millions)

Figure 9. Endocannabinoid System Targeted Therapeutics in Genetic Disorders

Figure 10. Global Endocannabinoid System Targeted Therapeutics Market: Genetic Disorders (2017-2022) & ($ Millions)

Figure 11. Endocannabinoid System Targeted Therapeutics in Neurological Disorders

Figure 12. Global Endocannabinoid System Targeted Therapeutics Market: Neurological Disorders (2017-2022) & ($ Millions)

Figure 13. Endocannabinoid System Targeted Therapeutics in Pain Disorders

Figure 14. Global Endocannabinoid System Targeted Therapeutics Market: Pain Disorders (2017-2022) & ($ Millions)

Figure 15. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application in 2021

Figure 16. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Player in 2021

Figure 17. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Endocannabinoid System Targeted Therapeutics Market Size 2017-2022 ($ Millions)

Figure 19. APAC Endocannabinoid System Targeted Therapeutics Market Size 2017-2022 ($ Millions)

Figure 20. Europe Endocannabinoid System Targeted Therapeutics Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size 2017-2022 ($ Millions)

Figure 22. Americas Endocannabinoid System Targeted Therapeutics Value Market Share by Country in 2021

Figure 23. Americas Endocannabinoid System Targeted Therapeutics Consumption Market Share by Type in 2021

Figure 24. Americas Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application in 2021

Figure 25. United States Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region in 2021

Figure 30. APAC Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application in 2021

Figure 31. China Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country in 2021

Figure 38. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type in 2021

Figure 39. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application in 2021

Figure 40. Germany Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Application in 2021

Figure 48. Egypt Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Endocannabinoid System Targeted Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. APAC Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. Europe Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. United States Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Canada Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. China Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Japan Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Korea Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. India Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Australia Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Germany Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. France Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. UK Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Italy Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Russia Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. Spain Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. Israel Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Endocannabinoid System Targeted Therapeutics Market Size 2023-2028 ($ Millions)